Sweden’s leading biopharmaceutical firm AstraZeneca is scheduled to invest US$220 million in Vietnam in the 2020 – 2024 period, according to Leif Johansson, chairman of AstraZeneca.
Prime Minister Nguyen Xuan Phuc paid a visit to AstraZeneca's headquarter in Sweden. Source: VGP.
|
Phuc lauded AstraZeneca’s successful business in Vietnam since the firm's entry in the country in 1994, saying its latest investment would contribute to greater cooperation between Vietnam and Sweden.
The Vietnamese government continues to create favorable conditions for Swedish companies, including AstraZeneca, that commit long-term business in the country, Phuc said.
According to Phuc, Vietnam’s average life expectancy stands at 75, among the highest in Asia, the country is seeking more international cooperation, in improving the healthcare sector.
Prime Minister Phuc tours the firm's lab. Source: VGP.
|
Baylan expected AstraZeneca’s investment in Vietnam would facilitate greater cooperation in pharmaceutical industry between Vietnam and Sweden.
Swedish companies want to expand their businesses globally, Baylan added, requesting the Vietnamese government to continue to give its support for their operation in Vietnam.
Aligned with the Government’s National Strategy for the Prevention and Control of Non-Communicable Diseases (2015 - 2025), AstraZeneca has focused on accelerating local investment for R&D as well as patients access to innovative healthcare solutions in Oncology, Cardiovascular, Renal and Metabolism, and Respiratory diseases. This includes the company’s US$20 million investment in clinical trials during period of 2017 - 2019 in Vietnam through a robust network of 132 local clinical research sites.
Another example is the partnership with Ministry of Health’s Medical Service Administration (MSA) for the Healthy Lung program. The US$1 million investment, announced in 2017, aims to improve the quality of outpatient management of asthma and Chronic Obstructive Pulmonary Disease (COPD) in Vietnam.
